Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 63INDUSTRY 41NIH 16NETWORK 6OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 55Gastrointestinal 28Gynecologic 11Breast 9Other hematologic neoplasm 7Genitourinary 5Lymphoid 4Head & Neck 4Dermatologic 3Classical hematology 3CNS 3Thoracic 2Sarcoma 2Other 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1NET 1Myeloid 1Endocrine 1

Conditions

Myelodysplastic Syndromes 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Myeloid, Acute 7Myeloproliferative Disorders 6Thrombocythemia, Essential 3Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Thrombocytosis 1Polycythemia Vera 1Papillomavirus Infections 1Neoplasms, Plasma Cell 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Hodgkin Disease 1Graft vs Host Disease 1Erectile Dysfunction 1Cardiovascular Diseases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasms × Myeloid × Clear all
NCT02161978 2019-11-06

DYVA-AAGG

University Hospital, Angers

Completed
93 enrolled
MyeloidOther hematologic neoplasm

Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡